HONG KONG, Feb. 28, 2017 -- UTStarcom (NASDAQ:UTSI), a global telecommunications infrastructure provider, announced today that it will report its unaudited financial results for the fourth quarter and full year 2016 ended December 31, 2016 before the U.S. market open on Friday, March 10, 2017. The Company will hold a conference call to discuss the financial results at 8:00 a.m. Eastern Time (9:00 p.m. Hong Kong/Beijing Time) the same day.
To participate in the call, please dial +1 (855) 298-3404 (domestic) or +1 (631) 514-2526 (international). The conference code is 3291531. This call will be webcast and can be accessed on the Investor Relations section of UTStarcom’s website at http://www.utstar.com.
United States: +1 (855) 298-3404
New York: +1 (631) 514-2526
Canada: +1 (855) 842-3490
Hong Kong: +852-5808-3202
China: 4001-200-539
The attendee passcode is: 3291531
A replay of the call will be available approximately two hours after the conclusion and will remain available for thirty calendar days.
The conference call replay numbers are as follows:
United States: +1 (866) 846-0868
Hong Kong: 800-966-697
China: 4001-842-240
International: +61-2-9641-7900
The replay passcode for accessing the recording is 3291531.
About UTStarcom Holdings Corp.
UTStarcom (NASDAQ:UTSI) is a global telecom infrastructure provider dedicated to developing technology that will serve the rapidly growing demand for bandwidth from cloud-based services, mobile, streaming and other applications. We work with carriers globally, from Asia to the Americas, to meet this demand through a range of innovative broadband packet optical transport and wireless/fixed-line access products and solutions. The Company’s end-to-end broadband product portfolio, enhanced through in-house Software Defined Networking (SDN)-based orchestration, enables mobile and fixed-line network operators and enterprises worldwide to build highly efficient and resilient future-proof networks for a range of applications, including mobile backhaul, metro aggregation, broadband access and Wi-Fi data offload. Our strategic investments in media operational support service providers expand UTStarcom’s capabilities in the field of next generation video platforms. UTStarcom was founded in 1991, started trading on NASDAQ in 2000, and has operating entities in Tokyo, Japan; San Jose, USA; Hangzhou, China; Delhi and Bangalore, India. For more information about UTStarcom, please visit http://www.utstar.com.
For investor and media inquiries, please contact: UTStarcom Holdings Corp. Tel: +852-3951-9757 Fei Wang, IR Director Email: [email protected] Ning Jiang, Investor Relations Email: [email protected] In the United States: The Blueshirt Group Ralph Fong Tel: +1 (415) 489-2195 Email: [email protected]


Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
L&F Tesla Battery Supply Deal Value Drops Sharply Amid EV Market Slowdown
Lockheed Martin Secures $92.8M AEGIS Sustainment Contract from U.S. Navy
Winter Storm Disrupts Northeast Travel as Snow and Ice Blanket New York, New Jersey
Anghami Stock Soars After Strong H1 2025 Results, Revenue Nearly Doubles on OSN+ Integration
Citigroup to Exit Russia With Sale of AO Citibank to Renaissance Capital
Lockheed Martin Secures Nearly $500 Million in U.S. and Allied Defense Contracts
Meta Acquires AI Startup Manus to Expand Advanced AI Capabilities Across Platforms
Leapmotor Targets 4 Million Annual EV Sales as Global Expansion Accelerates
Elon Musk’s xAI Expands Supercomputer Infrastructure With Third Data Center to Boost AI Training Power
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro
Boeing Secures $8.6 Billion Pentagon Contract for F-15 Jets for Israel
Disney Agrees to $10 Million Settlement Over Child Privacy Violations on YouTube
Lloyds Banking Group to Close Invoice Factoring Business by End of 2025
SoftBank Completes $41 Billion OpenAI Investment in Historic AI Funding Round
China’s LandSpace Takes Aim at SpaceX With Reusable Rocket Ambitions
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies 



